Abstract
Multiple sclerosis is characterized by a non-homogeneous distribution around the world. Some authors in past described a latitude gradient, with increasing risk from the equator to North and South Poles, but this theory is still controversial. Regarding Europe, there are many articles in the literature concerning the epidemiology of this disease but, unfortunately, they are not always comparable due to different methodologies, they do not cover all countries in the continent, and most of them reported data of small areas and rarely at a national level. In 2012 there were 20 national registries that could help to describe the epidemiology of the disease and, in addition, there is an European Register for Multiple Sclerosis that collect data from already existing national or regional MS registries and databases. Another valid alternative to obtain epidemiological data, also at national level, in a routinely and cost-saving way is through administrative data that are of increasing interest in the last years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- HLA:
-
human leukocyte antigen
- MS:
-
multiple sclerosis
- MSIF:
-
Multiple Sclerosis International Federation
- UK:
-
United Kingdom
- WHO:
-
World Health Organization
References
Ahlgren C, Odén A, Lycke J (2011) High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler 17(8):901–908
Ahlgren C, Odén A, Lycke J (2012) A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden. Mult Scler 18(8):1099–1107
Ahlgren C, Odén A, Lycke J (2014) High nationwide incidence of multiple sclerosis in Sweden. PLoS One 9(9):e108599
Alonso A, Hérnan MA (2008) Temporal trends in the incidence of multiple sclerosis. A systematic Rev Neurol 71:129–135
Atlas of MS 2013 http://www.msif.org/includes/documents/cm_docs/2013/m/msif-atlas-of-ms-2013-report.pdf?f=1
Bargagli AM, Colais P, Agabiti N et al (2016) Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems. J Neurol 263(4):751–759
Bártulos Iglesias M, Marzo Sola ME, Estrella Ruiz LA, Bravo Anguiano Y (2015) Epidemiological study of multiple sclerosis in La Rioja. Neurologia 30(9):552–560
Bellantonio P, Iuliano G, Di Blasio F, Ruggieri S (2013) Prevalence and incidence of multiple sclerosis in Campobasso (Molise region chieftown, Southern Italy). Clin Neurol Neurosurg 115(9):1806–1808
Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2014) High prevalence and no latitude gradient of multiple sclerosis in Norway. Mult Scler 20(13):1780–1782
Berg-Hansen P, Moen SM, Sandvik L et al (2015) Prevalence of multiple sclerosis among immigrants in Norway. Mult Scler 21(6):695–702
Bezzini D, Policardo L, Meucci G et al (2016) Prevalence of multiple sclerosis in Tuscany (Central Italy): a study based on validated sdministrative data. Neuroepidemiology 46:37–42
Bilancio sociale AISM (2014) http://bilanciosociale.aism.it/bilancio-sociale-2014/
Boĭko AN, Kukel’ TM, Lysenko MA, Vdovichenko TV, I. GE (2013) Clinical epidemiology of multiple sclerosis in Moscow. Descriptive epidemiology in population of one region of Moscow. Zh Nevropatol Psikhiatr Im S S Korsakova 113(10 Pt 2):8–14
Boĭko AN, Kukel’ TM, Lysenko MA, Vdovichenko TV, I. GE (2014) Clinical epidemiology of multiple sclerosis in Moscow. Сlinical demographic characteristics in population of one region of Moscow. Zh Nevropatol Psikhiatr Im S S Korsakova 114(2 Vypusk 2 Rasseiannyi skleroz):10–15
Brustad M, Alsaker E, Engelsen O et al (2004) Vitamin D status of middle-aged women at 65–71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 7:327–335
Burgaz A, Akesson A, Oster A et al (2007) Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter. Am J Clin Nutr 86:1399–1404
Cocco E, Sardu C, Massa R et al (2011) Epidemiology of multiple sclerosis in South-western Sardinia. Mult Scler 17(11):1282–1289
Culpepper WJ 2nd, Ehrmantraut M, Wallin MT, Flannery K, Bradham DD (2006) Veterans health administration multiple sclerosis surveillance registry: the problem of case-finding from administrative databases. J Rehabil Res Dev 43(1):17–24
de Sá J, Alcalde-Cabero E, Almazán-Isla J, Sempere A, de Pedro-Cuesta J (2012) Capture-Recapture as a potentially useful procedure for assessing prevalence of multiple sclerosis: methodologic exercise using Portuguese data. Neuroepidemiology 38:209–216
de Sá J, Alcalde-Cabero E, Almazán-Isla J, García-López F, de Pedro-Cuesta J (2014) Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998–2007. BMC Neurol 14:249
Di Domenicantonio R, Cappai G, Arcà M et al (2014) Occurrence of inflammatory bowel disease in central Italy: a study based on health information systems. Dig Liver Dis 46(9):777–782
El Adssi H, Debouverie M, Guillemin F, the LORSEP Group (2012) Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture–recapture method. Mult Scler 18(9):1244–1250
Eliasdottir OJ, Olafsson E, Kjartansson O (2011) Incidence of multiple sclerosis in Iceland, 2002–2007: a population-based study. Mult Scler 17(8):909–913
European Multiple Sclerosis Platform (EMSP). Multiple Sclerosis Information Dividend (MS-ID). MS Barometer 2011. www.emsp.org/attachments/article/160/MS-Barometer_2011.pdf
Fernández O, Fernández V, Guerrero M et al (2012) Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture–recapture method. Mult Scler 18(3):372–376
Figueiredo J, Silva Â, Cerqueira JJ, Fonseca J, Pereira PA (2015) MS prevalence and patients’ characteristics in the district of Braga, Portugal. Neurol Res Int 2015:895163
Flachenecker P (2014) Multiple sclerosis databases: present and future. Eur Neurol 72(Suppl 1):29–31
Flachenecker P, Stuke K (2008) National MS registries. J Neurol 255(Suppl 6):102–108
Flachenecker P, Buchow K, Pugliatti M et al (2014) Multiple sclerosis registries in Europe – results of a systematic survey. Mult Scler 20(11):1523–1532
Freisling H, Fahey MT, Moskal A et al (2010) Region-specific nutrient intake patterns exhibit a geographical gradient within and between European countries. J Nutr 140:1280–1286
Fromont A, Binquet C, Sauleau EA (2012) National estimate of multiple sclerosis incidence in France (2001–2007). Mult Scler 18(8):1108–1115
Gajofatto A, Stefani A, Turatti M et al (2013) Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. Eur J Neurol 20:697–703
Gavrilenko AA, Evdokimova ZS, Vasikovskaia GA, Boĭko AN (2012) Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions. Zh Nevropatol Psikhiatr Im S S Korsakova 112(2 Pt 2):5–8
Grytten N, Aarseth JH, Lunde HMB, Myhr KM (2016) A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway. J Neurol Neurosurg Psychiatry 87(1):100–105
Höer A, Schiffhorst G, Zimmermann A et al (2014) Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system. BMC Health Serv Res 14:381
Hurwitz BJ (2011) Analysis of current multiple sclerosis registries. Neurology 76:S7–S13
Izquierdo G, Venegas A, Sanabria C, Navarro G (2015) Long-term epidemiology of multiple sclerosis in the Northern Seville district. Acta Neurol Scand 132(2):111–117
Kampman MT, Brustad M (2008) Vitamin D. A candidate for the environmental effect in multiple sclerosis – observations from Norway. Neuroepidemiology 30:140–146
Kingwell E, Marriott JJ, Jetté N et al (2013) Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 13:128
Koch-Henriksen N, Sørensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520–532
Kolosynska OO (2013) Estimation of the multiple sclerosis risk in population living on contaminated territories after the Chornobyl catastrophe. Probl Radiat Med Radiobiol 18:82–88
Kotzamani D, Panou T, Mastorodemos V et al (2012) Rising incidence of multiple sclerosis in females associated with urbanization. Neurology 78:1728–1735
Kramer MA, van der Maas NAT, van Soest EM, Kemmeren JM, de Melker HE, Sturkenboom MCJM (2012) Incidence of multiple sclerosis in the general population in the Netherlands, 1996–2008. Neuroepidemiology 39:96–102
Krökki O, Bloigu R, Reunanen M, Remes AM (2011) Increasing incidence of multiple sclerosis in women in Northern Finland. Mult Scler 17(2):133–138
Kruja J, Beghi E, Zerbi D et al (2012) High prevalence of major neurological disorders in two Albanian communities: results of a door-to-door survey. Neuroepidemiology 38:138–147
Krysko KM, Ivers NM, Young J, O’Connor P, Tu K (2015) Identifying individuals with multiple sclerosis in an electronic medical record. Mult Scler 21(2):217–224
Kurtzke JF (1964) General features on the prevalence of multiple sclerosis. J Indian Med Prof 11:4896–4901
Kurtzke JF (1975) A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand 51:137–157
Lampis R, Morelli L, DeVirgiliis S, Congia M, Cucca F (2000) The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens 56:515–521
Last JM (2001) A dictionary of epidemiology, 4th edn. Oxford University Press, Oxford
Lix LM, Yogendran MS, Shaw SY, Burchill C, Metge C, Bond R (2008) Population-based data sources for chronic disease surveillance. Chronic Dis Can 29(1):31–38
Lonergan R, Kinsella K, Fitzpatrick P (2011) Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 82:317–322
Mackenzie IS, Morant SV, Bloomfield GA, MacDonald TM, O’Riordan J (2014) Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the general practice research database. J Neurol Neurosurg Psychiatry 85:76–84
Marrie RA, Yu N, Blanchard J, Leung S, Elliott L (2010) The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 74(6):465–471
Marrie, R. A., Yu, N., Leung, S., et al.; CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (2012) Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension and hyperlipidemia. Mult Scler 18(9): 1310–1319
Marrie, R. A., Yu, B. N., Leung, S., et al.; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (2013) The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology 40(2): 85–92
Marrosu MG, Cocco E, Lai M, Spinicci G, Pischedda MP, Contu P (2002) Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet 359:1461–1465
McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Melcon MO, Correale J, Melcon CM (2014) Is it time for a new global classification of multiple sclerosis? J Neurol Sci 344(1–2):171–181
Nicoletti A, Patti F, Lo Fermo S et al (2011) Increasing frequency of multiple sclerosis in Catania, Sicily: a 30-year survey. Mult Scler 17(3):273–280
Nicoletti A, Bruno E, Nania M et al (2013) Multiple sclerosis in the Mount Etna region: possible role of volcanogenic trace elements. PLoS One 8(12):e74259
Otero-Romero S, Roura P, Solà J et al (2013) Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain. Mult Scler 19(2):245–248
Otero-Romero S, Ramió-Torrentà L, Pericot I et al (2015) Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): evidence of increasing risk in the south of Europe. J Neurol Sci 359(1–2):146–150
Perković O, Jurjević A, Antončić I, Dunatov S, Bralić M, Ristić S (2010) The town of Čabar, Croatia, familiar pseudocluster for multiple sclerosis – descriptive epidemiological study. Coll Anthropol 34(Suppl 2):141–144
Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for MS: 2005 revision to the “McDonald Criteria”. Ann Neurol 58:840–846
Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302
Poser C, Paty D, Scheinberg L et al (1983) New diagnostic criteria for multiple sclerosis. Ann Neurol 13:227–231
Puthenparampil M, Seppi D, Rinaldi F et al (2013) Increased incidence of multiple sclerosis in the Veneto region, Italy. Mult Scler 19(5):601–604
Reinhardt K, Weiss S, Rosenbauer J, Gärtner J, von Kries R (2014) Multiple sclerosis in children and adolescents: incidence and clinical picture – new insights from the nationwide German surveillance (2009–2011). Eur J Neurol 21:654–659
Risberg G, Aarseth JH, Nyland H, Lauer K, Myhr KM, Midgard R (2011) Prevalence and incidence of multiple sclerosis in Oppland County – a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurol Scand 124(4):250–257
Rosati G (1994) Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 36(Suppl 2):S164–S174
Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117–139
Sardu C, Cocco E, Mereu A et al (2012) Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One 7(3):e32487
Simpson S Jr, Blizzard L, Otahal P, van der Mei I, Taylor B (2011) Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 82(10):1132–1141
Simpson S Jr, Mina S, Morris H, Mahendran S, Taylor B, Boggild M (2015) The epidemiology of multiple sclerosis in the Isle of Man: 2006–2011. Acta Neurol Scand 132(6):381–388
Solaro C, Ponzio M, Moran E et al (2015) The changing face of multiple sclerosis: prevalence and incidence in an aging population. Mult Scler 21(10):1244–1250
Sveinbjornsdottir S, Magnusson H, Benedikz JEG (2014) Multiple sclerosis in Iceland from 1900 to 2000: a total population study. Mult Scler Relat Dis 3(3):375–383
Svenningsson A, Salzer J, Vågberg M, Sundström P, Svenningsson A (2015) Increasing prevalence of multiple sclerosis in Västerbotten County of Sweden. Acta Neurol Scand 132(6):389–394
Tintoré M, Rovira A, Río J et al (2003) New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode. Neurology 60:27–30
Toncev G, Miletic Drakulic S, Knezevic Z et al (2011) Prevalence of multiple sclerosis in the Serbian district Sumadija. Neuroepidemiology 37(2):102–106
Türk Börü Ü, Taşdemir M, Güler N et al (2011) Prevalence of multiple sclerosis: door-to-door survey in three rural areas of Coastal Black Sea regions of Turkey. Neuroepidemiology 37(3–4):231–235
Vatne A, Mygland Å, Ljøstad U (2011) Multiple sclerosis in Vest-Agder County, Norway. Acta Neurol Scand 123(6):396–399
Visser EM, Wilde K, Wilson JF, Yong KK, Counsell CE (2012) A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city. J Neurol Neurosurg Psychiatry 83(7):719–724
Yaouanq J, Tron I, Kerbrat A et al (2015) Register-based incidence of multiple sclerosis in Brittany (North-western France), 2000–2001. Acta Neurol Scand 131(5):321–328
Zeqiraj K, Kruja J, Kabashi S, Muçaj S (2014) Epidemiological characteristics and functional disability of multiple sclerosis patients in Kosovo. Med Arh 68(3):178–181
Zikhova AR, Berezgova LM, Tlapshokova LB, Boĭko AN (2013) Epidemiological characteristics of multiple sclerosis in the Kabardino-Balkaria Republic. Zh Nevropatol Psikhiatr Im S S Korsakova 113(10 Pt 2):5–7
Zivadinov R, Iona L, Monti-Bragadin L et al (2003) The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology 22(1):65–74
Zsiros V, Fricska-Nagy Z, Füvesi J et al (2014) Prevalence of multiple sclerosis in Csongrád County, Hungary. Acta Neurol Scand 130(5):277–282
Acknowledgements
The authors thank Matteo Casarotto for a linguistic revision of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bezzini, D., Battaglia, M.A. (2017). Multiple Sclerosis Epidemiology in Europe. In: Asea, A., Geraci, F., Kaur, P. (eds) Multiple Sclerosis: Bench to Bedside. Advances in Experimental Medicine and Biology, vol 958. Springer, Cham. https://doi.org/10.1007/978-3-319-47861-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-47861-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47860-9
Online ISBN: 978-3-319-47861-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)